Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (341-350 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|July 1, 1982
Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery diseaseR M Califf, R A McKinnis, J Burks, et al.
Circulation|September 1, 1988
Current prognosis of ischemic mitral regurgitation. Implications for future managementM S Hickey, L R Smith, L H Muhlbaier, et al.
The American Journal of Cardiology|October 1, 1990
Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study GroupD W Muller, E J Topol, B S George, et al.
Journal of the American College of Cardiology|September 1, 1990
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosisC M O'Connor, R M Califf, E W Massey, et al.
American Heart Journal|April 1, 1990
One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trialR M Califf, E J Topol, B S George, et al.
Journal of the American College of Cardiology|March 21, 1998
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.
European Heart Journal|February 8, 2003
Predictors of 90-day outcome in patients stabilized after acute coronary syndromesL K Newby, M V Bhapkar, H D White, et al.
Journal of the American College of Cardiology|November 1, 1996
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventionsJ E O'Brien, E D Peterson, G P Keeler, et al.
Circulation|December 1, 1994
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesN S Kleiman, H D White, E M Ohman, et al.
The American Journal of Cardiology|June 1, 1994
Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study GroupR F Veldkamp, C L Green, M L Wilkins, et al.
Pageof 57

Showing results (341-350 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|July 1, 1982
Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery diseaseR M Califf, R A McKinnis, J Burks, et al.
Circulation|September 1, 1988
Current prognosis of ischemic mitral regurgitation. Implications for future managementM S Hickey, L R Smith, L H Muhlbaier, et al.
The American Journal of Cardiology|October 1, 1990
Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study GroupD W Muller, E J Topol, B S George, et al.
Journal of the American College of Cardiology|September 1, 1990
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosisC M O'Connor, R M Califf, E W Massey, et al.
American Heart Journal|April 1, 1990
One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trialR M Califf, E J Topol, B S George, et al.
Journal of the American College of Cardiology|March 21, 1998
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.
European Heart Journal|February 8, 2003
Predictors of 90-day outcome in patients stabilized after acute coronary syndromesL K Newby, M V Bhapkar, H D White, et al.
Journal of the American College of Cardiology|November 1, 1996
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventionsJ E O'Brien, E D Peterson, G P Keeler, et al.
Circulation|December 1, 1994
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesN S Kleiman, H D White, E M Ohman, et al.
The American Journal of Cardiology|June 1, 1994
Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study GroupR F Veldkamp, C L Green, M L Wilkins, et al.
Pageof 57